Operating income before deduction of amortization: fulgentgenetics.com (FLGT)

Brandmark of Fulgent Genetics Inc (FLGT)

Fulgent Genetics, Inc. (FLGT) is optimizing costs through bioinformatics automation, converting order growth into net income. The recorded EBITDA level visualizes this financial effect, where the 0.00 mark captures this metric. The company's algorithms accelerate the detection of oncological diseases for personalized treatment, while the development of spatial biology and AI-sequencing enhances its R&D potential within the pharmaceutical sector.

Profit before payment of interest, taxes and amortization: Fulgent Genetics, Inc. (FLGT) for 11/23/2025 - 11/12/2026

Fulgent Genetics - analytical breakdowns and key metrics (FLGT)

- market value and analyst target forecast:
Market Price Fulgent|FLGT - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Fulgent Genetics|FLGT - Enterprise Value
- balance sheet equity data:
Net Assets per Share Fulgent Genetics|FLGT - Company Book Value|Market Capitalization to Book Value fulgentgenetics.com|FLGT - Company Total Assets
- business debt structure and liquidity details:
Aggregate Debt to Equity Fulgent Genetics, Inc.|FLGT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Fulgent Genetics Inc|FLGT - Company Debts|Debt to Book Capitalization Ratio Fulgent Genetics|FLGT - Company Long-Term Debts|Short-Term Indebtedness Fulgent Genetics|Immediate Liquidity fulgentgenetics.com
- company profitability and valuation multiples indicators:
FLGT - Company Net Income|Net Profit Forecast Fulgent Genetics, Inc.|FLGT - Price to Earnings Ratio|Market Cap to Future Earnings Ratio fulgentgenetics.com|FLGT - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Fulgent Genetics|FLGT - Operating profit EBITDA|Net earnings per share for the trailing year Fulgent Genetics|FLGT - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months fulgentgenetics.com|FLGT - Earnings per share growth in current year|Projected earnings per share growth rate for next year Fulgent Genetics, Inc.
Analysis of all company metrics:Fulgent (FLGT)
Finished products of Fulgent Genetics

Absolute operating profit measures the amount of cash generated by assets before accounting for debt obligations and taxes. For Fulgent Genetics, Inc. (FLGT), this flow is driven by the scaling of rapid cancer diagnostic algorithms. By analyzing operating cash profit before deductions, an investor can discern the actual efficiency of laboratory capacities. The dynamics of the extremes here determine the market value of the business. However, the final valuation requires a comparison of profit against the debt load.

Who Fulgent Genetics, Inc. competes with

Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit EBITDA SHC|QDEL: Profit before deduction of interest, taxes, depreciation and amortization|OPKO Health - Operating profit before deduction of amortization|Operating profit EBITDA CareDx Corp CDNA|MRVI - Profit before payment of interest, taxes and amortization|LAB: Profit before payment of interest, taxes and amortization|CTKB: Operating profit EBITDA|Operating profit before depreciation charges orasure.com OSUR|XGN (Exagen Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization MDxHealth S.A. MDXH|Profit before payment of interest, taxes and amortization Lucid Diagnostics Inc (LUCD)|prenetics.com - Operating profit before amortization|Insight Molecular Diagnostics Inc - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization TRIB (Trinity Biotech PLC)|PRPH: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AIMD (Ainos Inc)|CODX: Operating profit EBITDA|Operating profit before depreciation charges Heart Test Labs HSCS|BMRA (Biomerica, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Cardio Diagnostics Holdings, Inc. CDIO|Profit before payment of interest, taxes and amortization Onconetix (ONCO)|Virax Biolabs Group Limited - Operating profit before amortization|Operating profit EBITDA BJDX (Bluejay)|Aspira Women's Health Inc (AWH) - Profit before interest, taxes and amortization|AXDX: Operating profit before deduction of amortization|Centogene - Company profit before taxes, interest and amortization|ENZ: Operating profit EBITDA|FRES - Operating income before deduction of amortization|GENE (Genetic Technologies Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization 23andMe Inc (ME)|Profit before payment of interest, taxes and amortization Psychemedics (PMD)